{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:03:24Z","timestamp":1786982604173,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Boehringer Ingelheim Pharma GmbH & Co. KG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13300-021-01024-y","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T03:02:26Z","timestamp":1615518146000},"page":"1209-1226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset"],"prefix":"10.1007","volume":"12","author":[{"given":"Maximilian","family":"Gabler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Picker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwin","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Aberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lehrke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"1024_CR1","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract."},{"issue":"15","key":"1024_CR2","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407\u201318.","journal-title":"N Engl J Med"},{"issue":"2","key":"1024_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.diabres.2014.08.002","volume":"106","author":"T Wilke","year":"2014","unstructured":"Wilke T, Groth A, Fuchs A, et al. Real life treatment of diabetes mellitus type 2 patients: an analysis based on a large sample of 394,828 German patients. Diabetes Res Clin Pract. 2014;106(2):275\u201385.","journal-title":"Diabetes Res Clin Pract"},{"issue":"14","key":"1024_CR4","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","volume":"290","author":"KMV Narayan","year":"2003","unstructured":"Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. J Am Med Assoc. 2003;290(14):1884\u201390.","journal-title":"J Am Med Assoc"},{"key":"1024_CR5","first-page":"69","volume":"111","author":"AFH Pfeiffer","year":"2014","unstructured":"Pfeiffer AFH, Klein HH. Therapie des diabetes mellitus typ 2. Dtsch Arztebl Int. 2014;111:69\u201382.","journal-title":"Dtsch Arztebl Int."},{"key":"1024_CR6","unstructured":"Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC), vol. 37. Oxford: Oxford University Press; 2016. p. 267\u2013315."},{"key":"1024_CR7","unstructured":"James S, Agewall S, Antunes MJ, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). http:\/\/www.escardio.org\/guidelines. Accessed 23 Jan 2020."},{"key":"1024_CR8","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (KBV), VersorgungsLeitlinien (NLV). Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz\u2013Langfassung, 3. Auflage. Version 1. 2019. http:\/\/www.akdae.de. Accessed 23 Jan 2020."},{"key":"1024_CR9","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (KBV), VersorgungsLeitlinien (NLV). Nationale VersorgungsLeitlinie Chronische KHK\u2014Langfassung, 5. Auflage. Version 1. 2019. http:\/\/www.akdae.de. Accessed 23 Jan 2020."},{"key":"1024_CR10","unstructured":"Endres M, Diener H, Behnke M, et al. S3-Leitlinie: Sekund\u00e4rprophylaxe\nisch\u00e4mischer Schlaganfall und transitorische isch\u00e4mische Attacke (AWMF-Register-Nr. 030\/133). 2015. http:\/\/www.dgn.org. Accessed 23 Jan 2020."},{"key":"1024_CR11","doi-asserted-by":"crossref","unstructured":"Bohn B, Sch\u00f6fl C, Zimmer V, et al. Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German\/Austrian DPV-multicenter analysis. Cardiovasc Diabetol. 2016;15:72. https:\/\/doi.org\/10.1186\/s12933-016-0391-8.","DOI":"10.1186\/s12933-016-0391-8"},{"issue":"6","key":"1024_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1177\/2047487314529353","volume":"22","author":"V Gyberg","year":"2015","unstructured":"Gyberg V, Kotseva K, Dallongeville J, et al. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study. Eur J Prev Cardiol. 2015;22(6):753\u201361.","journal-title":"Eur J Prev Cardiol"},{"key":"1024_CR13","unstructured":"Fricke U, G\u00fcnther J, Nieprasch-von Dollen K, Zawinell A. Anatomisch-therapeutisch-chemische-Klassifikation mit Tagesdosen Amtliche Fassung des ATC-Index mit DDD-Angaben f\u00fcr Deutschland im Jahre 2019. 2019. Berlin: Wissenschaftliches Institut der AOK"},{"issue":"11","key":"1024_CR14","first-page":"721","volume":"18","author":"HY Chang","year":"2012","unstructured":"Chang HY, Weiner JP, Richards TM, Bleich SN, Segal JB. Validating the adapted diabetes complications severity index in claims data. Am J Manag Care. 2012;18(11):721\u20136.","journal-title":"Am J Manag Care"},{"issue":"11","key":"1024_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245\u201351.","journal-title":"J Clin Epidemiol"},{"issue":"22","key":"1024_CR16","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"N Engl J Med."},{"issue":"22","key":"1024_CR17","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1161\/CIRCULATIONAHA.119.040130","volume":"139","author":"ET Kato","year":"2019","unstructured":"Kato ET, Silverman MG, Mosenzon O, et al. Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus. Circulation. 2019;139(22):2528\u201336.","journal-title":"Circulation"},{"issue":"4","key":"1024_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/CIRCULATIONAHA.117.032038","volume":"137","author":"KW Mahaffey","year":"2018","unstructured":"Mahaffey KW, Neal B, Perkovic V, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study). Circulation. 2018;137(4):323\u201334.","journal-title":"Circulation"},{"issue":"14","key":"1024_CR19","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","volume":"369","author":"WB White","year":"2013","unstructured":"White WB, Cannon CP, Heller SR, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013;369(14):1327\u201335.","journal-title":"N Engl J Med"},{"issue":"11","key":"1024_CR20","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/dom.12983","volume":"19","author":"SS Engel","year":"2017","unstructured":"Engel SS, Suryawanshi S, Stevens SR, et al. Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS. Diabetes Obes Metab. 2017;19(11):1587\u201393.","journal-title":"Diabetes Obes Metab"},{"issue":"14","key":"1024_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"BM Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013;369(14):1317\u201326.","journal-title":"N Engl J Med"},{"key":"1024_CR22","doi-asserted-by":"crossref","unstructured":"Shepherd J, Barter P, Carmena R, et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the treating to new targets (TNT) study. Diabetes Care. 2006;29(6):1220\u20136.","DOI":"10.2337\/dc05-2465"},{"key":"1024_CR23","doi-asserted-by":"crossref","unstructured":"Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670\u201381","DOI":"10.1016\/S0140-6736(10)61350-5"},{"issue":"4","key":"1024_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/eurheartj\/ehr400","volume":"33","author":"FA McAlister","year":"2012","unstructured":"McAlister FA. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials. Eur Heart J. 2012;33(4):505\u201314. https:\/\/doi.org\/10.1093\/eurheartj\/ehr400.","journal-title":"Eur Heart J."},{"key":"1024_CR25","doi-asserted-by":"publisher","unstructured":"Heart Outcomes Prevention Evaluation Study Investigators; Yusuf S, Sleight P, et al. Effects of an angiotensin-converting\u2013enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145\u201353. https:\/\/doi.org\/10.1056\/NEJM200001203420301.","DOI":"10.1056\/NEJM200001203420301"},{"key":"1024_CR26","doi-asserted-by":"crossref","unstructured":"Zelniker TA, Wiviott SD, Raz I, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393(10166):31\u20139.","DOI":"10.1016\/S0140-6736(18)32590-X"},{"key":"1024_CR27","doi-asserted-by":"crossref","unstructured":"Kristensen SL, R\u00f8rth R, Jhund PS, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019;7(10):776\u201385.","DOI":"10.1016\/S2213-8587(19)30249-9"},{"key":"1024_CR28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/CIRCULATIONAHA.119.041730","volume":"140","author":"SV Arnold","year":"2019","unstructured":"Arnold SV, De Lemos JA, Rosenson RS, et al. Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD). Circulation. 2019;140:618\u201320. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041730.","journal-title":"Circulation"},{"issue":"5","key":"1024_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P G\u00e6de","year":"2003","unstructured":"G\u00e6de P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383\u201393.","journal-title":"N Engl J Med."},{"issue":"7","key":"1024_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7326\/0003-4819-144-7-200604040-00005","volume":"144","author":"JB Saaddine","year":"2006","unstructured":"Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988\u20132002. Ann Intern Med. 2006;144(7):465\u201374.","journal-title":"Ann Intern Med"},{"issue":"17","key":"1024_CR31","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","volume":"368","author":"MK Ali","year":"2013","unstructured":"Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. Diabetes Care, 1999\u20132010. N Engl J Med. 2013;368(17):1613\u201324. https:\/\/doi.org\/10.1056\/NEJMsa1213829.","journal-title":"N Engl J Med."},{"issue":"10","key":"1024_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Anker SD, Dahlstr\u00f6m U, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013;15(10):1173\u201384.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"1024_CR33","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.ejheart.2007.09.008","volume":"9","author":"P de Groote","year":"2007","unstructured":"de Groote P, Isnard R, Assyag P, et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail. 2007;9(12):1205\u201311.","journal-title":"Eur J Heart Fail"},{"key":"1024_CR34","doi-asserted-by":"publisher","first-page":"e016835","DOI":"10.1161\/JAHA.120.016835","volume":"10","author":"AJ Nelson","year":"2021","unstructured":"Nelson AJ, Ardissino M, Haynes K, Shambhu S, Eapen ZJ, McGuire DK, et al. Gaps in evidence-based therapy use in insured patients in the United States with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. J Am Heart Assoc. 2021;10:e016835.","journal-title":"J Am Heart Assoc."},{"key":"1024_CR35","doi-asserted-by":"crossref","unstructured":"Hope HF, Binkley GM, Fenton S, Kitas GD, Verstappen SMM, Symmons DPM. Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease. PLoS One. 2019;14(1):e0201196.","DOI":"10.1371\/journal.pone.0201196"},{"issue":"9716","key":"1024_CR36","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735\u201342.","journal-title":"Lancet"},{"issue":"16","key":"1024_CR37","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/eurheartj\/ehi251","volume":"26","author":"M Komajda","year":"2005","unstructured":"Komajda M, Lapuerta P, Hermans N, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J. 2005;26(16):1653\u20139.","journal-title":"Eur Heart J"},{"key":"1024_CR38","doi-asserted-by":"crossref","unstructured":"Karlsson SA, Eliasson B, Franz\u00e9n S, Miftaraj M, Svensson AM, Andersson Sundell K. Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden. BMJ Open Diabetes Res Care. 2019;7(1):e000639.","DOI":"10.1136\/bmjdrc-2018-000639"},{"key":"1024_CR39","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2147\/DMSO.S214288","volume":"12","author":"T Wilke","year":"2019","unstructured":"Wilke T, Picker N, Mueller S, et al. Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage. Diabetes Metab Syndr Obes. 2019;12:1225\u201337.","journal-title":"Diabetes Metab Syndr Obes."},{"key":"1024_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565\u201374.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"6","key":"1024_CR41","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/01.HYP.2.6.757","volume":"2","author":"BR Haynes","year":"1980","unstructured":"Haynes RB, Taylor WD, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2(6):757\u201364.","journal-title":"Hypertension"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13300-021-01024-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T18:41:05Z","timestamp":1616697665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-021-01024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1007\/s13300-021-01024-y","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}